Drug Manufacturing During a Global Pandemic

Published on: 


***Wednesday, March 31, 2021, 11am EDT | 8am PDT | 3pm CEST | 4pm BST*** The COVID-19 pandemic has highlighted the importance of being prepared, planning ahead, and diversifying resources to assure continuity of manufacture and supply of life-sustaining medicines. Learn about best practices to anticipate, manage, and overcome unexpected challenges to drug production during a global emergency. *** On demand available after final airing until March 31, 2022.***

Register free: ​ https://www.pharmtech.com/pt_w/global

Event Overview:

The COVID-19 pandemic has brought into perspective the need for the bio/pharmaceutical industry to plan ahead, diversify supply chains and partner portfolio, and be sufficiently nimble to respond to the unanticipated and immediate needs in fighting a pandemic, as well as assure that the manufacture and supply of life-sustaining medicines spanning all therapeutic areas remains uninterrupted.

Bio/pharmaceutical companies must be prepared for tighter contract manufacturing capacity, pressure to produce drugs domestically, and materials and supply shortages. This webcast will present some of the pressing issues drug companies face, as well as options to mitigate these issues.

Key Learning Objectives:

  • Learn ways to manage the shortage of sterile manufacturing capacity contract development and manufacturing organizations as a result of unanticipated COVID-19 work
  • Understand the push to keep manufacturing within US borders to help to assure capacity and delivery.
  • Review the impact that a shortage of supplies (components, gowning, etc.) has on

Time and Date: Wednesday, March 31, 2021, 11am EDT | 8am PDT | 4pm BST | 5pm CEST

On demand available after final airing until March 31, 2022

Sponsor: AMRI

Register free: https://www.pharmtech.com/pt_w/global